No Data
No Data
Aoji Medical (688613.SH): Plans to increase capital of its wholly-owned subsidiary Weifang Aoji Health with a fundraising of 38.8 million yuan.
On July 26th, Gelunhui reported that Oujing Medical (688613.SH) plans to increase the capital of its wholly-owned subsidiary Weifang Oujing Health with a fundraising of 38.8 million yuan. The funds will be used for the investment project "Guiding Bone Regeneration Bone Repair Membrane/Dough-like Biomimetic Bone Repair Material/Bone Cement Modified with Artificial Bone Powder" and the investment project "Oujing Health Technology Industrial Park Construction Project". The sub-projects for the implementation of "Guiding Tissue Regeneration (GTR) Collagen Membrane" and "Collagen Protein Dressing for Skin Repair" respectively involve the amounts of 33 million yuan and 5.8 million yuan. Oujing Medical is also planning to raise a fundraising of RMB 977.0.
Aoxing medical (688613.SH) plans to distribute a dividend of 0.06 yuan per share in 2023, with ex-rights and ex-dividend on July 9th.
Ojion Medical (688613.SH) announced that the company plans to distribute a cash dividend of 0.06001 yuan per share (including tax) for the year 2023, with the record date on July 8, 2024 and the ex-dividend date on July 9, 2024.
Zhitong A Share Sale Restriction and Release List | May 21
According to the Zhitong Finance App, the ban on restricted shares of 4 listed companies was lifted on May 21, with a total market value of about 587 million yuan. Today's specific sales restrictions and unbanned stocks are as follows: Stock abbreviation, stock code, restricted stock type, number of shares unbanned, Jinzai Foods 003000, share incentives, limited sales and circulation 1615, Wanzhi, smart, 001339, share incentives, 6576, 10,000 Aojing Medical, 6886132.80741 million, Wanrun Xinneng, 68,2752.24 million
Aojing Healthcare (688613.SH): The ban on 2.80741 million restricted shares was lifted on May 21
Gelonghui, May 13 | Aojing Medical (688613.SH) announced that the total number of shares in circulation in the company's current stock listing was 28.741 million shares. The stock listing and circulation date is May 21, 2024.
Allgens Medical Technology (SHSE:688613) Posted Weak Earnings But There Is More To Worry About
Aojing Medical (688613.SH) announced its 2023 annual results. Net profit of 54.3218 million yuan decreased by 43.04% year on year
Aojing Medical (688613.SH) released its 2023 annual performance report. The company achieved operating revenue during the reporting period...
No Data